ObjectiveTo evaluate surgical treatment of chronic atrial fibrillation with ultrasound
in patients with mitral valve disease, considering preoperative clinical
characteristics of patients undergoing surgical procedure and follow-up in
the immediate postoperative period, in hospital and up to 60 months after
discharge.MethodsWe studied 100 patients with chronic atrial fibrillation and mitral valve
disease who underwent surgical treatment using ultrasound ablation. Patient
data were reviewed by consulting the control reports, including signs and
symptoms, underlying disease, functional class, hospital stay, surgical
procedure time, ablation time, immediate complications, and complications at
discharged and up to 60 months later. Actuarial curve (Kaplan-Meier) was
used for the study of permanence without recurrence after 12, 24, 36, 48 and
60 months.Results86% of the patients had rheumatic mitral valve disease, 14% had degeneration
of the mitral valve, 40% had mitral regurgitation, and 36% had mitral
stenosis. Main symptoms included palpitations related to tachycardia by
chronic atrial fibrillation (70%), congestive heart failure (70%), and
previous episodes of acute pulmonary edema (27%). Early results showed that
94% of the patients undergoing ultrasound ablation reversed the rate of
chronic atrial fibrillation, 86% being in sinus rhythm and 8% in
atrioventricular block. At hospital discharge, maintenance of sinus rhythm
was observed in 86% of patients and there was recurrence of chronic atrial
fibrillation in 8% of patients. At follow-up after 60 months, 83.8% of
patients maintained the sinus rhythm.ConclusionSurgical treatment of chronic atrial fibrillation with ultrasound concomitant
with mitral valve surgery is feasible and satisfactory, with maintenance of
sinus rhythm in most patients (83.8%) after 60 months of follow-up.